JTC Employer Solutions Trustee’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
JTC Employer Solutions Trustee's XBI Position: Q1 2026 in Review
JTC Employer Solutions Trustee reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 98% in Q1 2026, selling an estimated $10.4M and leaving 1,550 shares worth $198K. The position accounts for 0.02% of the portfolio, ranked #151.
JTC Employer Solutions Trustee first reported a position in XBI in Q2 2022 and has held it in 16 quarters since. The position peaked at $10.3M in Q4 2025. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.
- JTC Employer Solutions Trustee held 1,550 shares of State Street SPDR S&P Biotech ETF worth $198K as of Q1 2026.
- JTC Employer Solutions Trustee sold 83,195 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $10.4M.
- State Street SPDR S&P Biotech ETF made up 0.02% of JTC Employer Solutions Trustee's portfolio in Q1 2026, its #151 holding.
- JTC Employer Solutions Trustee first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and has held it in 16 quarters since.
- JTC Employer Solutions Trustee's State Street SPDR S&P Biotech ETF position peaked at $10.3M in Q4 2025.
- 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.
Based on JTC Employer Solutions Trustee's 13F filing for Q1 2026, filed 19 May 2026.